siRNAs as potential drugs

Drug Discovery Today. Technologies


No abstract listed.


Oct 3, 2002·Nature Reviews. Genetics·Michael T McManus, Phillip A Sharp
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Aug 28, 2003·Nature Cell Biology·Carol A SledzBryan R G Williams
Sep 17, 2004·Nature·Victor Ambros
Nov 3, 2004·Nucleic Acids Research·Raymond M SchiffelersMartin C Woodle
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher
May 24, 2005·Nature Biotechnology·Erwei SongJudy Lieberman
Sep 6, 2005·Science·Phillip D Zamore, Benjamin Haley
Dec 14, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adam D JudgeIan MacLachlan
Jan 21, 2006·Cancer Gene Therapy·G R Devi
Jun 3, 2006·Nucleic Acids Research·Ted C ChuMatthew Levy
Jul 11, 2006·Nature Biotechnology·James O McNamaraPaloma H Giangrande
Aug 1, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Martin SchleeGunther Hartmann
Mar 27, 2007·Cold Spring Harbor Symposia on Quantitative Biology·A K L Leung, P A Sharp
Jun 2, 2007·Nature Reviews. Drug Discovery·Antonin de FougerollesJudy Lieberman
Oct 12, 2007·Current Opinion in Chemical Biology·Christopher R Faehnle, Leemor Joshua-Tor
Apr 19, 2008·Nucleic Acids Research·Cecilia DahlgrenZicai Liang
Jan 31, 2009·Nature Reviews. Drug Discovery·Kathryn A WhiteheadDaniel G Anderson
Mar 20, 2009·The AAPS Journal·Bo YuRobert J Lee
Apr 7, 2009·Oligonucleotides·Anton A VolkovElena L Chernolovskaya
May 16, 2009·Oligonucleotides·Marjorie RobbinsIan MacLachlan
Jan 6, 2010·EMBO Molecular Medicine·Katrin Tiemann, John J Rossi
Jan 19, 2010·Nature Biotechnology·Sean C SempleMichael J Hope
Apr 3, 2010·Current Drug Metabolism·Yan WangAimin Ji
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·John DeVincenzoAkshay Vaishnaw
Aug 25, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Junmei HongZicai Liang

❮ Previous
Next ❯


❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.